US5341871094 - Common Stock

Taking everything into account, **LNC** scores **3** out of 10 in our fundamental rating. **LNC** was compared to 141 industry peers in the **Insurance** industry. **LNC** has a bad profitability rating. Also its financial health evaluation is rather negative. **LNC** has a valuation in line with the averages, but it does not seem to be growing. Finally **LNC** also has an excellent dividend rating.

In the past year **LNC** has reported a negative cash flow from operations.

The reported net income has been mixed in the past 5 years: **LNC** reported negative net income in multiple years.

In multiple years **LNC** reported negative operating cash flow during the last 5 years.

The **Return On Assets** of **LNC** (**0.43%**) is worse than **65.71%** of its industry peers.

The **Return On Invested Capital** of **LNC** (**0.52%**) is worse than **61.43%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.43% | ||

ROE | 20.74% | ||

ROIC | 0.52% |

ROA(3y)-0.14%

ROA(5y)0%

ROE(3y)-15.65%

ROE(5y)-8.05%

ROIC(3y)N/A

ROIC(5y)N/A

The **Operating Margin** of **LNC** (**14.43%**) is better than **64.29%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 14.43% | ||

PM (TTM) | 9.66% | ||

GM | N/A |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

The number of shares outstanding for **LNC** has been increased compared to 1 year ago.

Compared to 5 years ago, **LNC** has less shares outstanding

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.72 | ||

Debt/FCF | N/A | ||

Altman-Z | N/A |

ROIC/WACCN/A

WACCN/A

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | N/A | ||

Quick Ratio | N/A |

The **Earnings Per Share** has been decreasing by **-9.25%** on average over the past years.

The **Revenue** has been decreasing by **-3.31%** on average over the past years.

EPS 1Y (TTM)-33.39%

EPS 3Y6.93%

EPS 5Y-9.25%

EPS Q2Q%-8.91%

Revenue 1Y (TTM)-4.05%

Revenue growth 3Y-7.26%

Revenue growth 5Y-3.31%

Sales Q2Q%8.94%

Based on estimates for the next years, **LNC** will show a quite strong growth in **Earnings Per Share**. The EPS will grow by **17.64%** on average per year.

EPS Next Y11.54%

EPS Next 2Y20.89%

EPS Next 3Y17.12%

EPS Next 5Y17.64%

Revenue Next Year-0.85%

Revenue Next 2Y1.36%

Revenue Next 3Y1.84%

Revenue Next 5Y2.48%

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

The **Price/Earnings** ratio is **7.49**, which indicates a rather cheap valuation of **LNC**.

Based on the **Price/Earnings** ratio, **LNC** is valued a bit cheaper than 68.57% of the companies in the same industry.

The average S&P500 **Price/Earnings** ratio is at **29.62**. **LNC** is valued rather cheaply when compared to this.

Based on the **Price/Forward Earnings** ratio of **3.86**, the valuation of **LNC** can be described as very cheap.

Based on the **Price/Forward Earnings** ratio, **LNC** is valued cheaper than 82.14% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 7.49 | ||

Fwd PE | 3.86 |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | N/A |

The low **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as **LNC**'s earnings are expected to grow with **17.12%** in the coming years.

PEG (NY)0.65

PEG (5Y)N/A

EPS Next 2Y20.89%

EPS Next 3Y17.12%

Compared to an average S&P500 **Dividend Yield** of **2.26**, **LNC** pays a better dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 5.77% |

On average, the dividend of **LNC** grows each year by **10.89%**, which is quite nice.

Dividend Growth(5Y)10.89%

Div Incr Years0

Div Non Decr Years14

DP24.08%

EPS Next 2Y20.89%

EPS Next 3Y17.12%

**LINCOLN NATIONAL CORP**

NYSE:LNC (9/6/2024, 8:26:05 PM)

After market: 29.95 +0.5 (+1.7%)**29.45**

**-1.76 (-5.64%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupInsurance

GICS IndustryInsurance

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap5.01B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 5.77% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 7.49 | ||

Fwd PE | 3.86 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)0.65

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.43% | ||

ROE | 20.74% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 14.43% | ||

PM (TTM) | 9.66% | ||

GM | N/A | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.04

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.72 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | N/A | ||

Quick Ratio | N/A | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-33.39%

EPS 3Y6.93%

EPS 5Y

EPS Q2Q%

EPS Next Y11.54%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-4.05%

Revenue growth 3Y-7.26%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y